XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Sep. 30, 2022
Current assets:    
Cash and cash equivalents $ 24,596 $ 18,515
Restricted cash 0 465
Trade receivables and contract assets, net of allowances for credit losses of $7,523 and $6,268, respectively 74,014 100,073
Inventories, net 64,286 71,441
Prepaid expenses and other current assets 40,479 42,483
Assets held for sale 7,270 0
Total current assets 210,645 232,977
Property and equipment, net 188,496 186,199
Operating lease right-of-use assets, net 42,014 32,489
Goodwill 94,286 157,825
Other intangible assets, net 326,261 345,886
Other assets 6,964 7,524
Total assets 868,666 962,900
Current liabilities:    
Accounts payable 30,114 28,695
Accrued expenses and other liabilities 30,958 35,801
Revolving credit facility 0 15,000
Fees invoiced in advance 55,196 68,642
Current portion of long-term operating lease 10,061 7,982
Current portion of long-term debt 4,023 7,979
Liabilities held for sale 2,101 0
Total current liabilities 132,453 164,099
Long-term operating leases, net 32,730 24,854
Long-term debt, less current portion, net of debt issuance costs 370,040 330,677
Other long-term liabilities 6,023 6,477
Deferred tax liabilities, net 54,785 77,027
Total liabilities 596,031 603,134
Contingencies (Note 14)
Shareholders' equity and noncontrolling interest:    
Common shares, no par value: Authorized 74,000,000 shares at March 31, 2023 and at September 30, 2022; 25,759,107 issued and outstanding at March 31, 2023 and 25,598,289 at September 30, 2022 6,491 6,362
Additional paid-in capital 711,591 707,787
Accumulated deficit (444,838) (348,277)
Accumulated other comprehensive income (loss) 702 (5,500)
Total equity attributable to common shareholders 273,946 360,372
Noncontrolling interest (1,311) (606)
Total shareholders' equity and noncontrolling interest 272,635 359,766
Total liabilities and shareholders' equity and noncontrolling interest $ 868,666 $ 962,900